Key Details
Price
$6.97Annual ROE
-431.87%Beta
0.76Events Calendar
Next earnings date:
May 13, 2025Recent quarterly earnings:
Nov 7, 2024Recent annual earnings:
Mar 29, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Dec 29, 2023Analyst ratings
Recent major analysts updates
Feb 28, 25 Piper Sandler
OverweightDec 19, 24 BTIG
BuyDec 17, 24 LUCID CAPITAL MARKETS
BuyOct 24, 24 HC Wainwright & Co.
NeutralApr 16, 24 Oppenheimer
OutperformJun 27, 23 RBC Capital
Sector PerformJun 27, 23 Oppenheimer
PerformMay 10, 23 RBC Capital
OutperformFeb 8, 23 Jefferies
UnderperformMar 3, 22 RBC Capital
OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Avalo Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Avalo Therapeutics?
- Does Avalo Therapeutics pay dividends?
- What sector is Avalo Therapeutics in?
- What industry is Avalo Therapeutics in?
- What country is Avalo Therapeutics based in?
- When did Avalo Therapeutics go public?
- Is Avalo Therapeutics in the S&P 500?
- Is Avalo Therapeutics in the NASDAQ 100?
- Is Avalo Therapeutics in the Dow Jones?
- When was Avalo Therapeutics's last earnings report?
- When does Avalo Therapeutics report earnings?
- Should I buy Avalo Therapeutics stock now?
What is the ticker symbol for Avalo Therapeutics?
The ticker symbol for Avalo Therapeutics is NASDAQ:AVTX
Does Avalo Therapeutics pay dividends?
No, Avalo Therapeutics does not pay dividends
What sector is Avalo Therapeutics in?
Avalo Therapeutics is in the Healthcare sector
What industry is Avalo Therapeutics in?
Avalo Therapeutics is in the Biotechnology industry
What country is Avalo Therapeutics based in?
Avalo Therapeutics is headquartered in United States
When did Avalo Therapeutics go public?
Avalo Therapeutics's initial public offering (IPO) was on October 14, 2015
Is Avalo Therapeutics in the S&P 500?
No, Avalo Therapeutics is not included in the S&P 500 index
Is Avalo Therapeutics in the NASDAQ 100?
No, Avalo Therapeutics is not included in the NASDAQ 100 index
Is Avalo Therapeutics in the Dow Jones?
No, Avalo Therapeutics is not included in the Dow Jones index
When was Avalo Therapeutics's last earnings report?
Avalo Therapeutics's most recent earnings report was on Nov 7, 2024
When does Avalo Therapeutics report earnings?
The next expected earnings date for Avalo Therapeutics is May 13, 2025
Should I buy Avalo Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions